← Back to Clinical Trials
Recruiting NCT05678543

NCT05678543 Danish Diabetes Birth Registry 2

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05678543
Status Recruiting
Phase
Sponsor Odense University Hospital
Condition Pregnancy in Diabetic
Study Type OBSERVATIONAL
Enrollment 2,500 participants
Start Date 2023-01-01
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,500 participants in total. It began in 2023-01-01 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Pregnancies in women with pre-existing diabetes are considered "high risk" pregnancies, poses daily clinical challenges and in terms of research - a number of unanswered questions. Therefore, the investigators wish to establish a nationwide cohort of pregnancies complicated by pre-existing diabetes - the Danish Diabetes Birth Registry (DDBR2) The DDBR2 registry comprises all types of pre-existing diabetes including T1D, T2D and other types (as MODY), generating a nationwide cohort of mother/partner/children trios with accessible registry-, clinical data and biological biobank samples. This will enable the investigators to use data longitudinally to examine short- and long-term outcomes of pregnancies in women with diabetes.

Eligibility Criteria

Inclusion Criteria: * Women, age ≥ 18 years * Type 1 diabetes, type 2 diabetes or other types of pre-existing diabetes (e.g., maturity onset diabetes of the young (MODY)) * Partners of women fulfilling these inclusion criteria, age ≥ 18 years * Offspring of women fulfilling these inclusion criteria Exclusion Criteria: * No proficiency in Danish or English to understand oral and written information

Contact & Investigator

Central Contact

Sine K Johnsen, PhD

✉ sine.knorr@clin.au.dk

📞 +45 78 45 54 85

Principal Investigator

Dorte M Jensen, Prof.

PRINCIPAL INVESTIGATOR

Steno Diabetes Center Odense

Frequently Asked Questions

Who can join the NCT05678543 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Pregnancy in Diabetic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05678543 currently recruiting?

Yes, NCT05678543 is actively recruiting participants. Contact the research team at sine.knorr@clin.au.dk for enrollment information.

Where is the NCT05678543 trial being conducted?

This trial is being conducted at Aalborg, Denmark, Aarhus, Denmark, Copenhagen, Denmark, Odense, Denmark.

Who is sponsoring the NCT05678543 clinical trial?

NCT05678543 is sponsored by Odense University Hospital. The principal investigator is Dorte M Jensen, Prof. at Steno Diabetes Center Odense. The trial plans to enroll 2,500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology